1.Clinical Observation on Traditional Chinese Medicine Retention-enema Combined with Tamsulsosin Hydrochloride Capsules in Treating Chronic Abacterial Prostatitis/Chronic Pelvic Pain Syndrome
Xinping WANG ; Jianfeng YI ; Xingke YAN ; Chunlin ZHAO ; Haibang PAN ; Xiaopeng DONG
Chinese Journal of Information on Traditional Chinese Medicine 2014;(3):18-20
Objective To investigate the effect of traditional Chinese medicine retention-enema combined with tamsulsosin hydrochloride capsules in treating chronic abacterial prostatitis/chronic pelvic pain syndrome. Methods Two hundred patients of CABP/CPPS from Affiliated Hospital of Gansu University of TCM during September 2007-October 2012 were randomly divided into control group and observation group, 100 cases in each group. The control group received the treatment of tamsulsosin hydrochloride capsules, 0.2 mg/d, qn, and the observation group received the treatment of traditional Chinese medicine retention-enema additionally. The course was 4 weeks. The clinical effects of the two groups were observed and compared. The indexes including the scores of NIH-CPSI, leukocyte count and lecithin corpuscles in prostatic fluid, urinary flow rate were evaluated. Results The total effective rate was 100%(100/100) in observation group, and 88% (88/100) in control group. There was significant difference between the two groups (P<0.05). The scores of NIH-CPSI and leukocyte count in observation group were significantly lower than those in control group after treatment, with significant difference (P<0.05). The cases with lecithin corpuscles (++++) in observation group were more than those in control group (P<0.05). The peak flow rate and mean flow rate increased after treatment in both groups, and there was no statistically difference between the two groups (P>0.05). Conclusion Traditional Chinese medicine retention-enema combined with tamsulsosin hydrochloride capsules can significantly improve the clinical effect of CABP/CPPS.
2.Advances in the study of CAV1 in digestive tract tumors
Zhihang WU ; Mingzheng TANG ; Xiaofeng LI ; Yao RONG ; Yan CUI ; Haibang PAN
Chinese Journal of Comparative Medicine 2024;34(7):110-120
Digestive tract tumors are currently one of the most common types of cancer,including esophageal cancer,gastric cancer,hepatocellular carcinoma,pancreatic cancer,and colorectal cancer.Their prognoses are poor and the treatments require further improvement.Caveolin-1(CAV1)has a dual regulatory effect on digestive tract tumors as a tumor suppressor and cancer promoter.CAV 1 plays a major role in cell proliferation,invasion,metastasis,angiogenesis,and drug tolerance of digestive tract tumors.The regulation of CAV1 protein and its related signaling pathways may be a strategy for the treatment of digestive tract tumors.This review analyzes the relationship between CAV 1 and digestive tract tumors in terms of structure,function,expression regulation,regulation of epithelial-mesenchymal transition,and drug resistance in digestive tract tumors to provide new ideas for the diagnosis and treatment of digestive tract tumors.